Skip common site navigation and headers
US EPA
RCRA Online
Begin Hierarchical Links You are here: EPA Home >> Wastes >> Information Sources >> RCRA Online >> Document Record Detail End Hierarchical Links
Welcome What's New Topics Full Text Search Advanced Search Help

Document Record Detail



Full Document:
Title:APPLICABILITY OF PART 259 TO WASTES GENERATED IN THE TESTING OF BIOLOGICALS AND PHARMACEUTICALS
RCRA Online Number:11536
Date:07/10/1990
To:Nazario
From:Bussard
Organization of Recipient:Caribbean Bioresearch, Inc.
Description: Certain cytotoxic drugs are listed hazardous waste. Medical product testing (e.g., biologicals such as vaccines and cultures, and pharmaceuticals such as antibiotics and eye drops) may generate regulated medical waste. Compaction is not destruction. Liquid wastes disposed through a sewer are not subject to Part 259 (SUPERSEDED: see 60 FR 33912; 6/29/95).
Regulatory Citation(s) : 259.1 EXIT disclaimer
Statutory Citation(s):NA Read US Code 42, Chapter 82 EXIT disclaimer
Topic(s):Disposal; Medical Waste; Special Wastes
Approximate Number of Hardcopy Pages:4
EPA Publication Number:NA
RPPC Number (if applicable): NA
Official OSW Policy:No

 

 
Begin Site Footer

EPA Home | Privacy and Security Notice | Contact Us